Tanaka S - Search Results

1

Tanaka S. Tanaka S. No Shinkei Geka. 2021 May;49(3):623-631. doi: 10.11477/mf.1436204436. No Shinkei Geka. 2021. PMID: 34092568 Japanese.

2

Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.

Tanaka S, Meyer FB, Buckner JC, Uhm JH, Yan ES, Parney IF. Tanaka S, et al. J Neurosurg. 2013 Apr;118(4):786-98. doi: 10.3171/2012.10.JNS112268. Epub 2012 Nov 23. J Neurosurg. 2013. PMID: 23176331

3

Neuroendoscopic Ventriculocisternostomy with Stent Placement for Trapped Temporal Horn After the Resection of Glioblastoma.

Hana T, Tanaka S, Shin M, Mukasa A, Kugasawa K, Saito N. Hana T, et al. Among authors: tanaka s. World Neurosurg. 2015 Dec;84(6):2078.e5-8. doi: 10.1016/j.wneu.2015.08.019. Epub 2015 Aug 28. World Neurosurg. 2015. PMID: 26319190

4

Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy.

Tanaka S, Luk S, Kiyokawa J, Onozato ML, Iafrate AJ, Shah K, Martuza RL, Rabkin SD, Batchelor TT, Cahill DP, Chi AS, Wakimoto H. Tanaka S, et al. Sci Rep. 2019 Jan 15;9(1):139. doi: 10.1038/s41598-018-37437-2. Sci Rep. 2019. PMID: 30644426 Free PMC article.

5

PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastoma.

Tanaka S, Batchelor TT, Iafrate AJ, Dias-Santagata D, Borger DR, Ellisen LW, Yang D, Louis DN, Cahill DP, Chi AS. Tanaka S, et al. Acta Neuropathol Commun. 2019 Apr 29;7(1):66. doi: 10.1186/s40478-019-0720-8. Acta Neuropathol Commun. 2019. PMID: 31036078 Free PMC article.

6

A Novel Topical Fluorescent Probe for Detection of Glioblastoma.

Kitagawa Y, Tanaka S, Kamiya M, Kuriki Y, Yamamoto K, Shimizu T, Nejo T, Hana T, Matsuura R, Koike T, Yamazawa E, Kushihara Y, Takahashi S, Nomura M, Takami H, Takayanagi S, Mukasa A, Urano Y, Saito N. Kitagawa Y, et al. Among authors: tanaka s. Clin Cancer Res. 2021 Jul 15;27(14):3936-3947. doi: 10.1158/1078-0432.CCR-20-4518. Epub 2021 May 23. Clin Cancer Res. 2021. PMID: 34031057

7

Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study.

Aoki T, Kagawa N, Sugiyama K, Wakabayashi T, Arakawa Y, Yamaguchi S, Tanaka S, Ishikawa E, Muragaki Y, Nagane M, Nakada M, Suehiro S, Hata N, Kuroda J, Narita Y, Sonoda Y, Iwadate Y, Natsumeda M, Nakazato Y, Minami H, Hirata Y, Hagihara S, Nishikawa R. Aoki T, et al. Among authors: tanaka s. Int J Clin Oncol. 2021 Dec;26(12):2205-2215. doi: 10.1007/s10147-021-02028-1. Epub 2021 Sep 29. Int J Clin Oncol. 2021. PMID: 34586548 Free PMC article.

8

[Evolving Exploration of the Pathogenesis of CNS Germ Cell Tumors with Regard to Precision Medicine].

Takami H, Takayanagi S, Tanaka S, Saito N. Takami H, et al. Among authors: tanaka s. No Shinkei Geka. 2022 Jan;50(1):39-50. doi: 10.11477/mf.1436204530. No Shinkei Geka. 2022. PMID: 35169085 Japanese.

9

[Hemangioblastoma and von Hippel-Lindau Disease].

Takayanagi S, Takami H, Tanaka S, Saito N. Takayanagi S, et al. Among authors: tanaka s. No Shinkei Geka. 2022 Jan;50(1):101-110. doi: 10.11477/mf.1436204535. No Shinkei Geka. 2022. PMID: 35169090 Japanese.

10

[Molecularly Targeted Therapy for Craniopharyngioma].

Tanaka S, Takayanagi S, Takami H, Saito N. Tanaka S, et al. No Shinkei Geka. 2022 Jan;50(1):171-178. doi: 10.11477/mf.1436204542. No Shinkei Geka. 2022. PMID: 35169097 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,479 results

Search Page